Shatavari research is not confined to laboratories, but it is not a universal hormone treatment either. The species meant is Asparagus racemosus, not a thistle. A fair assessment considers positive human findings and their limits together.
What the 2025 investigation showed
A randomized, blinded trial assigned 80 women with symptoms during the transition to menopause to a shatavari root extract or placebo. After eight weeks, several symptom measures, including hot flushes, showed advantages. Seventy-three participants completed the trial according to protocol. [1]
This is a positive finding for a particular preparation in a selected population. It answers neither infertility treatment nor safety during pregnancy. Another extract or a homemade tea would also be a different application.
| What was studied | What is not automatically resolved |
|---|---|
| Symptoms around menopause | Every hormonal problem at every life stage. |
| A particular root extract | Equivalence of arbitrary powders and blends. |
| Eight weeks | Benefits and safety of years of intake. |
| Symptom assessment | An individually desired hormone value as a treatment target. |
Appropriate treatment remains a shared decision
The NHS describes hormone therapy, local treatments and cognitive behavioral therapy among possible approaches for menopausal symptoms. Selection depends on symptoms and personal circumstances. [2]
A herbal trial establishes neither that prescribed treatment is unnecessary nor that both applications can be combined without problems. Discuss the complete plan rather than adding individual products independently.
Document the concern specifically
For preparation, record typical symptoms, when they began and their effects on sleep or daily life. Bring labels for preparations already used as well. This supports a more focused question than a general search for hormonal balance.
Even after a positive trial result, it remains important to determine how personal benefit would be recognized and when use would be reviewed. An absent effect does not justify self-selected escalation. This article does not adopt a dose from the study protocol.
Frequently asked questions
Is there a positive human trial?
Yes. The investigation described provides signals for particular menopausal symptoms.
Does it prove general hormone balancing?
No. That broad claim exceeds the research question.
Is shatavari a thistle?
No. The species meant is Asparagus racemosus.
Can I infer clearance during pregnancy?
No. That application was not investigated.
Read more: Progesterone in targeted hormone treatment and Reading hormone values in context.
Sources
[1] Mahajan et al., 2025, PMID 41209045. [2] NHS: Treatment for menopause and perimenopause. Sources linked in the text; date: September 30, 2026. Not individual hormone, fertility or intake advice.
